Portugal Spain France Iceland UK Ireland Belgium Netherlands Germany Denmark Norway Finland Sweden Switzerland Italy Austria Czech Republik Slovakia Croatia Poland Hungary Romania Greece Lithuania Latvia Estonia Belarus Ukraina Serbia & Montenegro Bulgaria Moldavia Macedonia Albania
   

Vegetarians less likely to develop cancer than meat eaters

Vegetarians are 12 per cent less likely to develop cancer than meat eaters, according to new research published in the British Journal of Cancer. In a study of more than 61,000 people, Cancer Research UK scientists from Oxford followed meat eaters and vegetarians for over 12 years, during which 3,350 of the participants were diagnosed with cancer.

  

 

First ever study of European patients shows large numbers crossing borders for reproductive therapies

A substantial number of European patients travel to other countries for fertility treatment, both because they think that they will receive better quality care abroad and in order to undergo procedures that are banned in their home country says a study of the subject launched at the 25th annual conference of the European Society of Human Reproduction and Embryology.

  





 
   
 
 
 
 
 
 

   Featured companies
 
 
   
 
New Microneedle Applicator Device 
  Microneedles are designed to be painless whilst overcoming the natural barrier function of the skin that is located in the outermost layer of the epidermis, the stratum corneum (SC).
more
 
A diagnostic marker for early cancer detection
  Early stage diagnostics of cancer is important, because patients who are treated for cancer at an early stage have a higher chance on survival. The found marker has a high specificity and sensitivity and can be included in or developed into DNA methylation kits that are used for non-invasive detection of (pre-symptomatic) cancer such as fecal DNA testing.
more
 
 
02.07.2009 Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
 
02.07.2009 Lu AA24530 shows positive results in major depressive disorder phase II study
 
02.07.2009 MorphoSys and the University of Melbourne File New Patent Applications in MOR103 Program
 
01.07.2009 Amarin Reports Preliminary Unaudited Financial Results For The Six And Twelve Months Ended December 31, 2008
 
25.06.2009 Lundbeck receives FDA Complete Response Letter on Serdolect® for the treatment of schizophrenia
 
25.06.2009 Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial
 

24.06.2009 Safety Biomarkers in Drug Development,  Integrating biomarkers into clinical research to predict diagnose & avoid adverse events, September 14-15, 2009 Vienna, Austria
 
23.06.2009 Positive Phase I Trial Results for Pevion Biotech’s and Bio Life Science’s Breast Cancer Vaccine
 

23.06.2009 MediGene Concludes Agreement with Juste for the Commercialization of Veregen® in Spain and Portugal
 
22.06.2009 Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
 
22.06.2009 New Data from CLARITY Study Presented at 19th ENS Meeting Show Rapid and Sustained MS Relapse Reduction for Cladribine Tablets
 
22.06.2009 Merck presents biochromatography resin of a new performance class
 
Queen's study confirms teenagers are experimenting with cocaine
 
A revolutionary new protein stabilisation technique has been developed by scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) which could lead to 30 per cent more proteins being available as potential targets for drug development - opening up exciting possibilities in drug discovery.
 
New nanoparticles could revolutionise therapeutic drug discovery
 
A revolutionary new protein stabilisation technique has been developed by scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) which could lead to 30 per cent more proteins being available as potential targets for drug development - opening up exciting possibilities in drug discovery.